FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Corporate Results

Back
Sudarshan Pharma Industries consolidated net profit rises 51.39% in the December 2025 quarter
(07-Mar-2026, 07:27 Hours IST)  
Net profit of Sudarshan Pharma Industries rose 51.39% to Rs 4.36 crore in the quarter ended December 2025 as against Rs 2.88 crore during the previous quarter ended December 2024. Sales rose 45.26% to Rs 168.01 crore in the quarter ended December 2025 as against Rs 115.66 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales168.01115.66 45
OPM %6.476.90 -
PBDT6.114.48 36
PBT5.203.85 35
NP4.362.88 51

Powered by Capital Market - Live News

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)